loading

Finanzdaten der Diamedica Therapeutics Inc-Aktie (DMAC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
2.93%
5.822
5.656 6.47 4.983 3.928
Operating Income/Loss
1.68%
-8.007
-8.144 -8.419 -6.883 -5.638
Nonoperating Income/Loss
29.12%
0.314
0.443 - - -
Income/Loss From Continuing Operations Before Tax
0.10%
-7.693
-7.701 -7.891 -6.267 -5.112
Income Tax Expense/Benefit
0.00%
0.006
0.006 0.009 0.007 0.007
Income/Loss From Continuing Operations After Tax
0.10%
-7.699
-7.707 -7.90 -6.274 -5.119
Net Income/Loss
0.10%
-7.699
-7.707 -7.90 -6.274 -5.119
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.27%
42.96
42.84 0.8005 42.75 38.07
Basic Earnings Per Share
0.00%
-0.18
-0.18 -0.18 -0.15 -0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.43
price up icon 0.49%
$83.81
price down icon 1.12%
$26.75
price up icon 1.85%
$103.94
price down icon 1.02%
$131.00
price up icon 2.09%
biotechnology ONC
$307.65
price down icon 0.28%
Kapitalisierung:     |  Volumen (24h):